Blood Cells Molecules and Diseases: review time and acceptance speed
ISSN 1079-9796 · ISSN 1096-0961 · Elsevier BV · Medicine
Half of the articles Blood Cells Molecules and Diseases accepted in 2020 were accepted within 29 days of submission (n = 66); the middle half took 16–66 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Blood Cells Molecules and Diseases take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2020 | 66 | 16 | 29 | 66 | — | 21.2% | 83% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Distribution in 2020
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 34 | 51.5% |
| 30–59 | 14 | 21.2% |
| 60–89 | 10 | 15.2% |
| 90–119 | 8 | 12.1% |
| 120–149 | 0 | 0.0% |
| 150–179 | 0 | 0.0% |
| 180–209 | 0 | 0.0% |
| 210–239 | 0 | 0.0% |
| 240–269 | 0 | 0.0% |
| 270–299 | 0 | 0.0% |
| 300–329 | 0 | 0.0% |
| 330–359 | 0 | 0.0% |
| 360+ | 0 | 0.0% |
From acceptance to online publication
After acceptance, half of the 2020 articles appeared online within 4 days (middle half 2–9 days, n = 66).
From submission to online publication, the median was 37 days (middle half 19–70 days, n = 66).
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Subscription or hybrid (not determined). Listed APC: about $4,030 (as reported by OpenAlex).
No institutional payments for this journal are recorded in OpenAPC.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | No |
|---|---|
| Articles indexed for MEDLINE in 2020 | Yes |
| Retractions | 0 retracted articles among 172 added to PubMed in 2021–2025, per the Retraction Watch Database. |
| Accepted within 14 days of submission | 21.2% of 2020 articles |
| Publication volume | 68 articles added to PubMed in 2020. |
Topics and scope
- Hemoglobinopathies and Related Disorders (18% of indexed topics)
- Iron Metabolism and Disorders (12% of indexed topics)
- Erythrocyte Function and Pathophysiology (9% of indexed topics)
- Lysosomal Storage Disorders Research (5% of indexed topics)
- Acute Myeloid Leukemia Research (4% of indexed topics)
- Blood groups and transfusion (4% of indexed topics)
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2020 figures are compared with the 2020 median of Blood Cells Molecules and Diseases, 29 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Acta Haematologica | 77 (2020, n = 84) | — | — | No | Yes |
| American Journal of Hematology | 47 (2020, n = 192) | ≈$5,450 | — | No | Yes |
| Indian Journal of Hematology and Blood Transfusion | 111 (2020, n = 139) | ≈$2,390 | — | No | No |
| Mediterranean Journal of Hematology and Infectious Diseases | 68 (2020, n = 85) | ≈$923 | — | Yes | No |
| British Journal of Haematology | 57 (2020, n = 340) | ≈$5,190 | — | No | Yes |
| Blood Reviews | 147 (2020, n = 80) | ≈$5,220 | — | No | Yes |
| Journal of Blood Medicine | 80 (2020, n = 58) | $3,940 | — | Yes | No |
| International Journal of Laboratory Hematology | 84 (2020, n = 193) | ≈$3,880 | — | No | Yes |
| Hematology Transfusion and Cell Therapy | 89 (2020, n = 123) | No fee (DOAJ) | — | Yes | No |
No journals match these filters.
Frequently asked questions
How long does Blood Cells Molecules and Diseases take to accept a paper?
Half of the articles Blood Cells Molecules and Diseases accepted in 2020 were accepted within 29 days of submission (n = 66); the middle half took 16–66 days. Based on dates in PubMed for accepted articles only.
How long after acceptance are Blood Cells Molecules and Diseases articles published online?
Half of the articles accepted in 2020 appeared online within 4 days of acceptance (n = 66).
Does Blood Cells Molecules and Diseases charge an article processing charge (APC)?
Listed APC: about $4,030 (as reported by OpenAlex).
Sources and method
Journal identity: ISSN-L 1079-9796; NLM ID 9509932; OpenAlex record. Speed figures use 66 articles accepted in 2020 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.